CClinicalTrials.gg
CompletedNCT05462886Updated Sep 24, 2024Results posted

Clinical Performance of Masimo INVSENSOR00057 for Heart Rate Measurements

An interventional study of Masimo INVSENSOR00057 in Healthy, sponsored by Masimo Corporation. Completed at 1 site in United States. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-09-24.

Sponsored by Masimo Corporation · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
86
Allocation
Not applicable
Ages
18 Years to 80 Years
Sex
All
01

Study summary

This study is designed to compare the accuracy of a noninvasive measurement of heart rate compared to reference values obtained by a standard of care ECG monitor.

02

Conditions studied

  • Healthy
03

In context

Lead sponsor

Masimo Corporation is the lead sponsor of 103 studies on the registry; 1 is open to participants now.

Of its 78 completed or terminated interventional studies of FDA-regulated products, 65 (83%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Subject is 18 to 80 years of age.
  • Subject is able to read and communicate in English.

Exclusion criteria

Exclusion Criteria:

  • Subject has open wounds, inflamed tattoos or piercings on the area of device placement, and/or has any visible healing wounds that the investigator and/or medical professional determines may place them at an increased risk for participation.
  • Subject has any medical condition which in the judgment of the investigator and/or study staff, renders them ineligible for participation in this study or subject is deemed ineligible by the discretion of the investigator/study staff.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
86 participants (actual)

Study arms

  • Experimental
    Masimo INVSENSOR00057

    All subjects who are enrolled into the test group and participate in data collection receive the noninvasive Masimo INVSENSOR00057 device.

    Device: Masimo INVSENSOR00057

Interventions

  • DeviceMasimo INVSENSOR00057

    Noninvasive wearable health monitoring device

06

What researchers measure

Primary outcomes

  1. Heart Rate Accuracy of Masimo INVSENSOR00057

    Heart rate accuracy was determined by calculating the accuracy root mean-squared (Arms) difference between the measured values from Masimo INVSENSOR00057 (TestHR_i) to the reference ECG monitor values (RefHR_i). Arms= √(∑(i=1 to n) ((TestHR_i-RefHR_i )\^2 ))/n

    Time frame: 1-3 hours

07

Results

Posted May 29, 2024

Participant flow

Participant flow — Overall Study
MilestoneMasimo INVSENSOR00057
Started86
Completed79
Not completed7

Outcome measures

PrimaryHeart Rate Accuracy of Masimo INVSENSOR00057

Heart rate accuracy was determined by calculating the accuracy root mean-squared (Arms) difference between the measured values from Masimo INVSENSOR00057 (TestHR_i) to the reference ECG monitor values (RefHR_i). Arms= √(∑(i=1 to n) ((TestHR_i-RefHR_i )\^2 ))/n

Time frame:
1-3 hours
Reported as:
Number · bpm
Heart Rate Accuracy of Masimo INVSENSOR00057
bpmINVSENSOR00057
Heart Rate Accuracy of Masimo INVSENSOR000571.38

Adverse events

Collected over 1-3 hours. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Masimo INVSENSOR000570/86 (0%)0/86 (0%)0/86 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Masimo INVSENSOR00057
<=18 years0
Between 18 and 65 years79
>=65 years0
Sex: Female, Male
Sex: Female, Male(Participants)Masimo INVSENSOR00057
Female36
Male43
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Masimo INVSENSOR00057
American Indian or Alaska Native0
Asian21
Native Hawaiian or Other Pacific Islander0
Black or African American5
White21
More than one race8
Unknown or Not Reported24
Region of Enrollment
Region of Enrollment(participants)Masimo INVSENSOR00057
United States79
08

Study locations

1 site
  • Masimo Corporation
    Irvine, California 92618, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Apr 4, 2022

Documents are hosted by the registry — open the source record to download them.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 24, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05462886
Lead sponsor
Masimo Corporation
Responsible party
Sponsor
First posted
Jul 18, 2022
Start date
Jul 8, 2022
Primary completion
Jul 21, 2022
Completion
Jul 21, 2022
Results posted
May 29, 2024
Last update
Sep 24, 2024

Oversight

FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion